Aion Therapeutic (XCNQ:AION) Institutional Ownership : 0.05% (As of Jun. 12, 2024)

View and export this data going back to 2019. Start your Free Trial

What is Aion Therapeutic Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Aion Therapeutic's institutional ownership is 0.05%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Aion Therapeutic's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Aion Therapeutic's Float Percentage Of Total Shares Outstanding is 0.00%.

Aion Therapeutic Institutional Ownership Historical Data

The historical data trend for Aion Therapeutic's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aion Therapeutic Institutional Ownership Chart

Aion Therapeutic Historical Data

The historical data trend for Aion Therapeutic can be seen below:

	2020-07-31	2020-08-31	2020-09-30	2020-10-31	2020-11-30	2020-12-31	2021-01-31	2021-02-28	2021-03-31	2021-04-30
Institutional Ownership	0.06	0.06	0.06	0.06	0.06	0.06	0.05	0.05	0.05	0.05

Aion Therapeutic Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

Aion Therapeutic (XCNQ:AION) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aion Therapeutic Inc (XCNQ:AION) » Definitions » Institutional Ownership

Comparable Companies

Traded in Other Exchanges

ANTCF:USA

Address

700 West Georgia Street, Suite 2200, Vancouver, BC, CAN, V7Y 1K8

Website

https://www.aiontherapeutic.com

Aion Therapeutic Inc is in the business of research and development, treatment, data mining, and state of the art artificial intelligence techniques, focused on the development of combinatorial pharmaceuticals, nutraceuticals, and cosmeceuticals utilizing compounds from cannabis, psychedelic mushrooms, fungi, natural psychedelic formulations, and other medicinal plants in a legal environment for this type of discovery.

Executives

Ismail Abdul Fattah

Director or Senior Officer of 10% Security Holder

Aion Therapeutic (XCNQ:AION) Headlines

No Headlines